US FDA seeks feedback on record-keeping requirements for medtech
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is giving the medical device industry the opportunity to comment on the record-keeping obligations required of them under current good manufacturing practice (cGMP) quality system (QS) rules1.